Literature DB >> 6417538

Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms.

A Arnold, J Cossman, A Bakhshi, E S Jaffe, T A Waldmann, S J Korsmeyer.   

Abstract

Immunoglobulin genes in their germ-line form are separated DNA subsegments that must be joined by means of recombinations during B-cell development. Individual immunoglobulin-gene rearrangements are specific for a given B cell and its progeny. We show that the detection of such gene rearrangements by Southern hybridization provides a sensitive marker for both clonality and B-cell lineage within lymphoid tissues lacking expression of definitive surface phenotypes. We have used these genetic markers in three ways: to establish a diagnosis of lymphoma in a neoplastic disorder of uncertain cell type, to show that some lymphomas that were previously classified as being of T-cell type in fact contain monoclonal B cells, and to detect clonal B-cell populations within lymphomatous tissues of uncertain immunotype and within an atypical lymphofollicular hyperplasia having no other clonal surface markers. These sensitive and unique indicators of clonality located directly at the DNA level are capable of providing insights into the cellular origin, early detection, and natural history of neoplasia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417538     DOI: 10.1056/NEJM198312293092601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  103 in total

1.  Reactive and neoplastic lymphocytes in human bone marrow: morphological, immunohistological, and molecular biological investigations on biopsy specimens.

Authors:  S M Kröber; H P Horny; A Greschniok; E Kaiserling
Journal:  J Clin Pathol       Date:  1999-07       Impact factor: 3.411

2.  An unusual allelic form of the immunoglobulin lambda constant region genes in the Japanese.

Authors:  P H Kay; J Moriuchi; P J Ma; E Saueracker
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  Molecular-genetic analysis of ocular adnexal benign lymphoid hyperplasias by a two-step polymerase-chain-reaction.

Authors:  Y Takano; M Okudaira
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

4.  Rapid, nonradioactive detection of clonal T-cell receptor gene rearrangements in lymphoid neoplasms.

Authors:  A Bourguin; R Tung; N Galili; J Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

5.  The suitability of matrix assisted laser desorption/ionization time of flight mass spectrometry in a laboratory developed test using cystic fibrosis carrier screening as a model.

Authors:  Daniel H Farkas; Nicholas E Miltgen; Jay Stoerker; Dirk van den Boom; W Edward Highsmith; Lesley Cagasan; Ron McCullough; Reinhold Mueller; Lin Tang; John Tynan; Courtney Tate; Allan Bombard
Journal:  J Mol Diagn       Date:  2010-07-08       Impact factor: 5.568

6.  Kappa-chain gene rearrangement in an apparent T-lineage lymphoma.

Authors:  K Ha-Kawa; J Hara; Y Keiko; A Muraguchi; N Kawamura; S Ishihara; S Doi; H Yabuuchi
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

7.  T-cell/histiocyte-rich large B-cell lymphoma.

Authors:  Stefania Pittaluga; Elaine S Jaffe
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

8.  Primary pulmonary lymphoma diagnosed by gene rearrangement: report of a case.

Authors:  H Miura; O Taira; O Uchida; N Kajiwara; H Kato
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

9.  Gene rearrangement studies on lymphoma of the lung: report of a case.

Authors:  T Aoki; M Watanabe; K Takagi; S Tanaka; S Aida
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

10.  B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation.

Authors:  L M Nadler; S J Korsmeyer; K C Anderson; A W Boyd; B Slaughenhoupt; E Park; J Jensen; F Coral; R J Mayer; S E Sallan
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.